Skip to content

Clinical trials

Phase 1/2 Head and Neck Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Head and Neck Neoplasms Phase: Phase 1/2 Country / region: South Korea Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20173
20181
20193
20202
20212
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting4
Recruiting4
Completed2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
BicycleTx Limited1
Bolt Biotherapeutics, Inc.1
CytomX Therapeutics1
GeneMedicine Co., Ltd.1
Hoffmann-La Roche1
Inhibrx Biosciences, Inc1
Merus B.V.1
PMV Pharmaceuticals, Inc1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Head and Neck Neoplasms12
Carcinoma, Non-Small-Cell Lung10
Lung Neoplasms7
Colorectal Neoplasms6
Neoplasms6
Breast Neoplasms5
Colonic Neoplasms5
Neoplasms by Site5
Bronchial Neoplasms4
Carcinoma, Bronchogenic4

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.